Industries > Pharma > Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine

PUBLISHED: 01 August 2017
PAGES: 227
PRODUCT CODE: PHA0219

Clear
WOOCS 2.2.1

The Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027: Analysis and Forecasts for Mammalian Cell Cultures, Microbial Fermentations, Other Expression Systems, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines and Geography report reviews the contract active pharmaceutical ingredient (API) manufacturing market for biologics. This study gives quantitative and qualitative analysis for that overall world market, as well as for countries and other submarkets, including the mammalian cell culture and microbial fermentation segments. This report assesses leading applications and significant developments within each, as well as drivers and restraints for them. Future trends that will affect the biotech API manufacturing services market are also examined. In addition, this study profiles leading contract manufacturing organisations (CMOs) in the outsourcing market and assesses their outlooks. Visiongain provides forecasts revenues for the period 2016 to 2027 for the biotech API manufacturing services market, as well as for therapeutic applications.

How this 227 page report delivers:
• Provides qualitative and quantitative analysis of the leading submarkets the period 2017-2027. Visiongain forecasts revenues and their growth for these submarkets:
– Mammalian cell culture
– Microbial fermentation
– Other expression platforms

• Provides qualitative and quantitative analysis of the leading contract API biological drug applications for the period 2017-2027. Visiongain forecasts contract API drug revenues to 2027 for these individual segments:
– Monoclonal antibody (mAb) therapies
– Vaccines
– Insulin therapies
– Interferon therapies
– Growth hormones.

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

• Find forecasts of the leading therapeutic and national markets from 2016 to 2027:
– The EU, including the five leading markets (UK, Germany, France, Italy and Spain).
– The US
– Japan
– Switzerland
– Emerging markets such as the BRIC (Brazil, Russia, India, and China) countries, South Korea and Singapore.

• Profiles leading global and national companies that offer biotech API manufacturing services to the pharmaceutical industry. For each company, current services offered, recent developments and outlooks are discussed. Leading CMOs profiled in this chapter are:
– Boehringer Ingelheim BioXcellence
– Celltrion
– DSM Biologics
– Lonza
– Samsung BioLogics
– Cytovance Biologics
– Fujifilm Diosynth Biotechnologies
– Operations of leading biopharma companies, such as AbbVie, GSK and Novartis.

• Discover the regulatory outlook for biotech API manufacturing in leading regional and national markets in 2017, as well as predicted developments for the period to 2027.

• Identify important drug development and technology trends that will affect CMOs, their clients and other market participants from 2017. The report also contains SWOT and STEP analysis of the industry and market.

• Find profiles for leading CMOs offering biological drug API manufacturing services to pharmaceutical companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories